HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

E Bloch-Shilderman Selected Research

Benactyzine

1/2019Repetitive antidotal treatment is crucial in eliminating eye pathology, respiratory toxicity and death following whole-body VX vapor exposure in freely moving rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


E Bloch-Shilderman Research Topics

Disease

2Miosis
08/2015 - 05/2014
2Vision Disorders (Hemeralopia)
08/2015 - 05/2014
1Corneal Injuries
01/2019
1Weight Loss (Weight Reduction)
01/2019
1Clinical Deterioration
01/2019
1Wounds and Injuries (Trauma)
05/2011
1Cardiac Arrhythmias (Arrythmia)
05/2011

Drug/Important Bio-Agent (IBA)

3OximesIBA
01/2019 - 05/2014
3SarinIBA
08/2015 - 05/2011
2AtropineFDA LinkGeneric
01/2019 - 08/2015
2Cholinergic Antagonists (Anticholinergics)IBA
01/2019 - 05/2014
1BenactyzineIBA
01/2019
1Ophthalmic Solutions (Eye Drops)IBA
08/2015
1TropicamideFDA LinkGeneric
08/2015
1Cholinesterase Inhibitors (Anticholinesterases)IBA
05/2014
1Epinephrine (Adrenaline)FDA LinkGeneric
05/2011